Common Contracts

Vaccine Adjuvant License and Collaboration Agreement

Confidential Treatment • March 5th, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Minnesota

• Contract Type
  Confidential Treatment
• Filed
  March 5th, 2009
• Company
  Celldex Therapeutics, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Minnesota

This Agreement is made on the 30th day of May, 2008 (“Effective Date”) by and among 3M COMPANY (“3M”) and 3M INNOVATIVE PROPERTIES COMPANY (“3M IPC”), a wholly-owned subsidiary of 3M, both with a principal address as 3M Center, St. Paul, MN 55144 (collectively “3M”); and Celldex Therapeutics, with a principal address at 222 Cameron Drive Suite 400, Phillipsburg, NJ 08865 (“CELLDEX”).

Vaccine Adjuvant License and Collaboration Agreement

Confidential Treatment • March 2nd, 2009 • Celldex Therapeutics Inc • Biological products, (no disgnostic substances) • Minnesota

• Contract Type
  Confidential Treatment
• Filed
  March 2nd, 2009
• Company
  Celldex Therapeutics Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Minnesota

This Agreement is made on the 30th day of May, 2008 (“Effective Date”) by and among 3M COMPANY (“3M”) and 3M INNOVATIVE PROPERTIES COMPANY (“3M IPC”), a wholly-owned subsidiary of 3M, both with a principal address as 3M Center, St. Paul, MN 55144 (collectively “3M”); and Celldex Therapeutics, with a principal address at 222 Cameron Drive Suite 400, Phillipsburg, NJ 08865 (“CELLDEX”).